By the way, you guys should know that the ClinTex CTi platform will enable more efficient clinical trials and is targeted at the clinical trials industry which is currently worth $350 billion.
What are the different types of clinical trials you are going to start once the platform is released? Whether do you have any experienced people who are pharma background because this thing should be done under a provision of experienced people?
Hi btcyoda,
Initial deployments of the CTi platform will be in academic clinical trials – Specifically utilising our partnership with Intellimed in research projects run by the largest NHS trust in the UK. However, these academic research applications of CTi are simply to serve as a foundation to refine the platform and demonstrate benefits for use in large scale pharmaceutical trials. The main power and application of the CTi platform will therefore be in late phase clinical trials (i.e. Phase IIb/Phase III) and in Post Marketing studies (Phase IV). This is where the full extent of CTi analytics can deliver most efficiency savings.
In answer to the second part of your question, we have significant experience on the team from the medical and more importantly, pharmaceutical and clinical trial background (see
https://www.clintex.io/home#team). This experience at this stage is pivotal to guiding our CTi development and deployment strategy. When it comes to real-world implementation, we have, and will continue to build our project management and developer expertise to ensure successful and impactful deployments of CTi. At this stage, we do not propose to actually run or manage clinical trials on behalf of pharmaceutical companies, and so our clinical trial expertise will continue to be consultative rather than hands on. Our Mission is to provide the industry the tools to make their own clinical trial more efficient, and to help them deliver faster medicines at lower cost.
Show Posts
